TLX short interest
Telix Pharmaceuticals Limited · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 426,829 |
|---|---|
| Change vs prior report | 74,305 (+21.1%) |
| Change over six months | +39.5% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 542,786 |
| Rank in Healthcare | #779 of 922 by days to cover |
TLX short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 426,829 | +21.1% | 1.00 | 542,786 |
| 2026-09-15 | 352,524 | +33.1% | 1.00 | 400,077 |
| 2026-08-31 | 264,943 | +8.2% | 1.80 | 147,160 |
| 2026-08-14 | 244,900 | -11.8% | 2.31 | 106,104 |
| 2026-07-31 | 277,664 | -6.5% | 2.56 | 108,323 |
| 2026-07-15 | 297,140 | +82.7% | 1.80 | 165,030 |
| 2026-06-30 | 162,625 | -16.2% | 1.00 | 213,105 |
| 2026-06-15 | 193,969 | -22.8% | 1.00 | 235,552 |
| 2026-05-29 | 251,276 | +15.6% | 2.15 | 116,627 |
| 2026-05-15 | 217,298 | -19.6% | 1.87 | 116,382 |
| 2026-04-30 | 270,088 | -30.9% | 1.54 | 175,239 |
| 2026-04-15 | 390,717 | +27.7% | 1.56 | 250,731 |
| 2026-03-31 | 306,000 | +69.2% | 1.20 | 255,851 |
| 2026-03-13 | 180,832 | -51.6% | 1.00 | 312,004 |
| 2026-02-27 | 373,450 | +66.3% | 1.07 | 349,910 |
| 2026-02-13 | 224,523 | +69.3% | 1.20 | 187,061 |
| 2026-01-30 | 132,629 | -24.8% | 1.00 | 170,212 |
| 2026-01-15 | 176,460 | +125.2% | 1.09 | 161,962 |
| 2025-12-31 | 78,342 | -31.5% | 1.00 | 230,978 |
| 2025-12-15 | 114,355 | +15.1% | 1.00 | 150,387 |
| 2025-11-28 | 99,377 | -18.9% | 1.21 | 82,005 |
| 2025-11-14 | 122,491 | +1.2% | 1.46 | 83,809 |
| 2025-10-31 | 121,036 | +16.1% | 1.45 | 83,493 |
| 2025-10-15 | 104,272 | -32.8% | 1.00 | 129,056 |
| 2025-09-30 | 155,162 | +30.8% | 1.00 | 252,529 |
import finzdata as yf
yf.Ticker("TLX").short_interest # every report since 2017
yf.Client().short_interest(["TLX"], start="2018-01-01")Healthcare short interest · TLX price history · Who owns TLX · All short interest